Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest.
Open Access
- 1 February 1998
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 77 (3) , 404-411
- https://doi.org/10.1038/bjc.1998.64
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Relationship of Mitotic Arrest and Apoptosis to Antitumor Effect of PaclitaxelJNCI Journal of the National Cancer Institute, 1996
- An aggressive nasal lymphoma accompanied by high levels of soluble Fas ligandBritish Journal of Haematology, 1996
- Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice.Journal of Clinical Investigation, 1996
- Local Fas/APO‐1 (CD95) ligand‐mediated tumor cell killing in vivoEuropean Journal of Immunology, 1995
- In vitro assessment of Taxol for human glioblastomaAnti-Cancer Drugs, 1995
- Cytotoxicity of taxol in vitro against human and rat malignant brain tumorsCancer Chemotherapy and Pharmacology, 1994
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993
- A saturation threshold for taxol cytotoxicity in human glial and neuroblastoma cellsAnti-Cancer Drugs, 1993
- Shared Actions of Endotoxin and Taxol on TNF Receptors and TNF releaseScience, 1990
- Effects of recombinant human tumor necrosis factor-α on the surface phenotype and the growth of human malignant glioma cell linesInternational Journal of Cancer, 1988